Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:NVIV

InVivo Therapeutics (NVIV) Stock Price, News & Analysis

InVivo Therapeutics logo

About InVivo Therapeutics Stock (NASDAQ:NVIV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.22
$0.79
52-Week Range
N/A
Volume
1.89 million shs
Average Volume
8.25 million shs
Market Capitalization
$997 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive NVIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InVivo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

NVIV Stock News Headlines

InVivo Therapeutics Holdings Co (NVIVQ)
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
InVivo Therapeutics Holdings Corp (NVIVQ)
InVivo Therapeutics Holdings Corporation
InVivo Therapeutics Holdings Corp.
See More Headlines

NVIV Stock Analysis - Frequently Asked Questions

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) released its quarterly earnings results on Wednesday, May, 13th. The biotechnology company reported ($61.75) EPS for the quarter.

InVivo Therapeutics's stock reverse split on Wednesday, April 27th 2022.The 1-25 reverse split was announced on Wednesday, April 27th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, April 27th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that InVivo Therapeutics investors own include Anavex Life Sciences (AVXL), Gilead Sciences (GILD), Tonix Pharmaceuticals (TNXP), Flexion Therapeutics (FLXN), OPKO Health (OPK), Acasti Pharma (ACST) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
5/13/2020
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:NVIV
CIK
1292519
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$10.49 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$6.48 per share
Price / Book
N/A

Miscellaneous

Free Float
3,029,000
Market Cap
$997 thousand
Optionable
Not Optionable
Beta
0.65

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:NVIV) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners